Average Co-Inventor Count = 2.37
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Esbatech, an Alcon Biomedical Research Unit LLC (27 from 36 patents)
2. Numab Therapeutics Ag (8 from 12 patents)
3. Novartis Ag (6 from 3,923 patents)
4. Other (1 from 832,891 patents)
5. Numab Innovation Ag (1 from 3 patents)
6. Esbatech, an Alcon Biomedical Unit LLC (1 from 1 patent)
7. Esbatech, an Alcon Biomedical Reseach Unit LLC (1 from 1 patent)
8. Esbatech, an Aclon Biomedical Research Unit LLC (1 from 1 patent)
9. Esbatech, an Alcon Boimedical Research Unit, LLC (1 from 1 patent)
10. Esbatech - a Novartis Company LLC (1 patent)
47 patents:
1. 12202911 - Multispecific antibody comprising CD137 binding domain and PDL1 binding domain
2. 12098203 - Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA
3. 11879005 - Hetero-dimeric multi-specific antibody format
4. 11858981 - Humanization of rabbit antibodies using a universal antibody framework
5. 11578123 - Stable and soluble antibodies inhibiting TNFα
6. 11427628 - Antibody frameworks
7. 11421035 - Stable antibody variable domain framework combinations and methods of use thereof
8. 11319371 - Anti-CD3 antibodies
9. 11236150 - Hetero-dimeric multi-specific antibody format
10. 11046757 - Solubility optimization of immunobinders
11. 10781268 - Method for decreasing immunogenicity
12. 10590193 - Stable and soluble antibodies inhibiting VEGF
13. 10570198 - Stable and soluble antibodies
14. 10221237 - Solubility optimization of immunobinders
15. 10174102 - Antibody frameworks